|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/06 | |
| A61K 38/15 | |||
| A61K 47/06 | |||
| A61K 47/14 | |||
| A61K 9/00 | |||
| A61P 17/00 |
| (11) | Number of the document | 2699231 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12723241.1 |
| Date of filing the European patent application | 2012-04-18 | |
| (97) | Date of publication of the European application | 2014-02-26 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2012/051946 |
| Date | 2012-04-18 |
| (87) | Number | WO 2012/143868 |
| Date | 2012-10-26 |
| (30) | Number | Date | Country code |
| 201161477297 P | 2011-04-20 | US |
| (72) |
HAUG, Claire, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPSIPEPTIDE |
| SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPSIPEPTIDE |